This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
The sequence datasets analysed by QIIME2 in this article are publicly available in the NCBI BioProject database, under the accession number PRJNA557226. Sequencing data analysis scripts and the R code used for downstream analysis and generating the plots are available at GitHub (https://github.com/Fangxi-Xu/Pancan).
References
Fletcher, A. A. et al. Revisiting the intrinsic mycobiome in pancreatic cancer. Nature https://doi.org/10.1038/s41586-023-06292-1 (2023).
Aykut, B. et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574, 264–267 (2019).
Alam, A. et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell 40, 153–167.e11 (2022).
Ghaddar, B. et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell 40, 1240-1253.e5 (2022).
Dohlman, A. B. et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell 185, 3807–3822.e12 (2022).
Haziza, L. N. et al. Pan-cancer characterization of the tumor mycobiome and its clinical effects. Cancer Res. 82, 3054 (2022).
Shiao, S. L. et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell 39, 1202–1213.e6 (2021).
Fierer, N., Jackson, J. A., Vilgalys, R. & Jackson, R. B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl. Environ. Microbiol. 71, 4117–4120 (2005).
Jian, C., Luukkonen, P., Yki-Järvinen, H., Salonen, A. & Korpela, K. Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling. PLoS ONE 15, e0227285 (2020).
Pushalkar, S. et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 8, 403–416 (2018).
Anslan, S. et al. Great differences in performance and outcome of high-throughput sequencing data analysis platforms for fungal metabarcoding. MycoKeys 39, 29–40 (2018).
Prodan, A. et al. Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing. PLoS ONE 15, e0227434 (2020).
Navas-Molina, J. A. et al. Advancing our understanding of the human microbiome using QIIME. Methods Enzymol. 531, 371–444 (2013).
Moeller, J. B. et al. Modulation of the fungal mycobiome is regulated by the chitin-binding receptor FIBCD1. J. Exp. Med. 216, 2689–2700 (2019).
Kõljalg, U. et al. Towards a unified paradigm for sequence-based identification of fungi. Mol. Ecol. 22, 5271–5277 (2013).
Narunsky-Haziza, L. et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell 185, 3789–3806.e17 (2022).
Li, X. & Saxena, D. The tumor mycobiome: a paradigm shift in cancer pathogenesis. Cell 185, 3648–3651 (2022).
Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104–108 (2018).
Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178, 795–806.e12 (2019).
Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 3 (2011).
Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019).
Kõljalg, U. et al. UNITE: a database providing web-based methods for the molecular identification of ectomycorrhizal fungi. New Phytol. 166, 1063–1068 (2005).
Acknowledgements
This work was supported by the National Institutes of Health, US grants RO1 CA206105 (to D.S.), DOD W81XWH-19-1-0605 (to D.S.) and R41 CA250892 (to D.S.).
Author information
Authors and Affiliations
Contributions
D.S., S.P. and G.M. wrote the Reply. F.X. and S.P. analysed the data and designed the figures. All authors verified the content.
Corresponding author
Ethics declarations
Competing interests
D.S. is a co-founder of PeriomicsCare LLC. G.M. is a founding advisor and holds equity in Zephyr AI. F.X. and S.P. declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Xu, F., Saxena, D., Pushalkar, S. et al. Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer. Nature 620, E7–E9 (2023). https://doi.org/10.1038/s41586-023-06293-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-023-06293-0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.